Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
2018-09-12
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if giving reolysin in combination with FOLFOX6/
bevacizumab can offer better results than standard therapy with FOLFOX6/ bevacizumab.